Metabolic Reprogramming and Risk Stratification of Hepatocellular Carcinoma Studied by Using Gas Chromatography–Mass Spectrometry-Based Metabolomics

SIMPLE SUMMARY: Hepatocellular carcinoma (HCC) displays dismal prognosis even after surgical resection. Metabolic reprogramming is a hallmark of cancers, but the existence of tumor heterogeneity makes it difficult to comprehensively reflect the overall characteristics of HCC prognosis with only a si...

Descripción completa

Detalles Bibliográficos
Autores principales: Fang, Chengnan, Wang, Hui, Lin, Zhikun, Liu, Xinyu, Dong, Liwei, Jiang, Tianyi, Tan, Yexiong, Ning, Zhen, Ye, Yaorui, Tan, Guang, Xu, Guowang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8750553/
https://www.ncbi.nlm.nih.gov/pubmed/35008393
http://dx.doi.org/10.3390/cancers14010231

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8750553/
https://www.ncbi.nlm.nih.gov/pubmed/35008393
http://dx.doi.org/10.3390/cancers14010231

Ejemplares similares